Cargando…
A Novel Therapy for Huntington’s Disease
In 1979, while at the National Institutes of Health, now Columbia University professor Nancy Wexler and colleagues traveled to Venezuela to study the world’s largest family with Huntington’s disease. That led to identifying the disease gene at the tip of human chromosome 4 and the race to find a dru...
Autor principal: | La Spada, Albert R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Dana Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353115/ https://www.ncbi.nlm.nih.gov/pubmed/30746028 |
Ejemplares similares
-
Déjà vu with a twist: transglutaminases in bioenergetics and transcriptional dysfunction in Huntington's disease
por: Kazemi-Esfarjani, Parsa, et al.
Publicado: (2010) -
The expanding world of stem cell modeling of Huntington's disease: creating tools with a promising future
por: Ward, Jacqueline M, et al.
Publicado: (2012) -
Targeting the Cholinergic System to Develop a Novel Therapy for Huntington’s Disease
por: D’Souza, Gary X., et al.
Publicado: (2016) -
PPARδ repression in Huntington’s disease and its essential role in CNS translate into a potent agonist therapy
por: Dickey, Audrey S., et al.
Publicado: (2015) -
Novel targets for Huntington’s disease: future prospects
por: Mason, Sarah L, et al.
Publicado: (2016)